XML 39 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Other Paid-in Capital
Retained Earnings
Deferred Retirement Benefit Costs
Accumulated Other Comprehensive Income
Total Ameren Corporation Shareholders' Equity
Noncontrolling Interests
Union Electric Company
Union Electric Company
Common Stock
Union Electric Company
Other Paid-in Capital
Union Electric Company
Preferred Stock
Union Electric Company
Retained Earnings
Ameren Illinois Company
Ameren Illinois Company
Common Stock
Ameren Illinois Company
Other Paid-in Capital
Ameren Illinois Company
Preferred Stock
Ameren Illinois Company
Retained Earnings
Beginning of year at Dec. 31, 2020     $ 6,179 $ 2,757 $ (1)     $ 142     $ 2,518   $ 2,101     $ 2,652 $ 62 $ 2,252
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Settlement of forward sale agreement through common shares issuance     113                              
Shares issued under the DRPlus and 401(k) plan     12                              
Stock-based compensation activity     (9)                              
Capital contributions from parent                 $ 113   113     $ 40   40    
Net income $ 235               48       48 150       150
Net income attributable to Ameren common shareholders 233     233                            
Dividends on common stock       (140)                            
Preferred stock dividends                         (1)         (1)
Change in deferred retirement benefit costs 1       1                          
Net income attributable to noncontrolling interest holders $ (2)             2                    
Dividends paid to noncontrolling interest holders               (2)                    
Redemptions of preferred stock               (13)                 (13)  
Common stock shares outstanding at beginning of year (in shares) at Dec. 31, 2020 253,300,000                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under forward sale agreement (in shares) 1,600,000                                  
Shares issued under the DRPlus and 401(k) plan 100,000                                  
Shares issued for stock-based compensation (in shares) 500,000                                  
Common stock shares outstanding at end of period (in shares) at Mar. 31, 2021 255,500,000                                  
End of period at Mar. 31, 2021 $ 9,277 $ 3 6,295 2,850 0 $ 0   129   $ 511 2,631 $ 80 2,148   $ 0 2,692 49 2,401
Shareholders' equity, end of year at Mar. 31, 2021             $ 9,148   5,370         5,142        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Dividends per common share (in dollars per share) $ 0.55                                  
Beginning of year at Dec. 31, 2021 $ 9,829   6,502 3,182 13     129     2,725   2,595     2,914 49 2,677
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Settlement of forward sale agreement through common shares issuance     0                              
Shares issued under the DRPlus and 401(k) plan     13                              
Stock-based compensation activity     (8)                              
Capital contributions from parent                 0   0     0   0    
Net income 253               $ 51       51 $ 169       169
Net income attributable to Ameren common shareholders 252     252                            
Dividends on common stock       (152)                            
Preferred stock dividends                         (1)         0
Change in deferred retirement benefit costs 1       1                          
Net income attributable to noncontrolling interest holders $ (1)             1                    
Dividends paid to noncontrolling interest holders               (1)                    
Redemptions of preferred stock               0                 0  
Common stock shares outstanding at beginning of year (in shares) at Dec. 31, 2021 257,700,000               102,100,000         25,500,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Shares issued under forward sale agreement (in shares) 0                                  
Shares issued under the DRPlus and 401(k) plan 100,000                                  
Shares issued for stock-based compensation (in shares) 400,000                                  
Common stock shares outstanding at end of period (in shares) at Mar. 31, 2022 258,200,000               102,100,000         25,500,000        
End of period at Mar. 31, 2022 $ 9,935 $ 3 $ 6,507 $ 3,282 $ 14 $ 14   $ 129   $ 511 $ 2,725 $ 80 $ 2,645   $ 0 $ 2,914 $ 49 $ 2,846
Shareholders' equity, end of year at Mar. 31, 2022 $ 9,806           $ 9,806   $ 5,961         $ 5,809        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Dividends per common share (in dollars per share) $ 0.59